To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants
Clinical trial NCT07237464 · RECRUITING
Trial details
- NCT number
- NCT07237464
- Sponsor
- Shenzhen Kexing Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2026-01-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.